Oral contraception in Denmark 1998-2010

被引:19
作者
Wilson, Nadia M. [1 ]
Laursen, Maja [2 ]
Lidegaard, Ojvind [1 ]
机构
[1] Univ Copenhagen, Rigshosp, Univ Hosp, Gynecol Clin, DK-2100 Copenhagen, Denmark
[2] Danish Med Agcy, Copenhagen, Denmark
关键词
Combined oral contraceptives; estrogen dose; oral contraceptives; progestins; progestogens;
D O I
10.1111/j.1600-0412.2012.01416.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. Oral contraceptives (OC) are the most popular contraception in Denmark. Overall figures on use are well described, but more detailed use patterns according to type and age need to be updated. Objectives. To assess trends in the use of OC including progestogen-only pills among Danish women in 19982010 and to describe in detail use patterns in 2010. Design. Annual cross-sectional prescription statistics. Setting. Denmark. Population. Danish women 1049 years old. Material and methods. Analysis of prescription data from the National Registry of Medicinal Products Statistics from 1 January 1998 through 31 December 2010. Results. Combined OC (COC) with 50 mu g estrogen decreased their market share from 3% in 1998 to zero in 2010, and COC with 3040 mu g estrogen decreased to 50% in 2010, in contrast, COC with 20 mu g estrogen increased to 46% in 2010. Progestogen-only pills accounted for 4%. COC with levonorgestrel decreased, while the use of pills with desogestrel and gestodene among two-thirds of current users was constant. Conclusion. Low-dose COCs gradually replaced middle-dose pills. Pills with newer progestogens are used primarily by young women, and 85% of users in 2010 were on products with desogestrel, gestodene, drospirenone or cyproteroneacetate. We still need low-dose pills with 1st and 2nd generation progestogens on the Scandinavian market.
引用
收藏
页码:810 / 815
页数:6
相关论文
共 50 条
[21]   Multiple hepatocellular adenomas in a patient with a history of oral contraception [J].
Caballes, RL ;
Caballes, RA .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1999, 64 (02) :177-180
[22]   Oral contraception and cyclic changes in premenstrual and menstrual experiences [J].
Abraham, S ;
Luscombe, G ;
Soo, I .
JOURNAL OF PSYCHOSOMATIC OBSTETRICS & GYNECOLOGY, 2003, 24 (03) :185-193
[23]   Safety concerns and health benefits associated with oral contraception [J].
Burkman, R ;
Schlesselman, JJ ;
Zieman, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (04) :S5-S22
[24]   THE IMPACT OF ORAL CONTRACEPTION ON VULVO-VAGINAL CANDIDIASIS [J].
SPINILLO, A ;
CAPUZZO, E ;
NICOLA, S ;
BALTARO, F ;
FERRARI, A ;
MONACO, A .
CONTRACEPTION, 1995, 51 (05) :293-297
[25]   Oral contraception and epilepsy: findings in a large cohort study [J].
Vessey, M ;
Painter, R ;
Yeates, D .
CONTRACEPTION, 2002, 66 (02) :77-79
[26]   Biphasic versus monophasic oral contraceptives for contraception: a Cochrane review [J].
Van Vliet, HAAM ;
Grimes, DA ;
Helmerhorst, FM ;
Schulz, KF .
HUMAN REPRODUCTION, 2002, 17 (04) :870-873
[27]   Usage of condom by adolescents advising for the oral contraception in the region of Montreal [J].
Rodrigues, I ;
Dedobbeleer, N ;
Turcot, C .
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2005, 96 (06) :438-442
[28]   Venous thrombembolism, thrombophilic defects, combined oral contraception and anticoagulation [J].
Ott, Johannes ;
Promberger, Regina ;
Kaufmann, Ulrike ;
Huber, Johannes C. ;
Frigo, Peter .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 280 (05) :811-814
[29]   Oral contraception and smoking - Time trends for a risk behaviour in Finland [J].
Kosunen, EAL ;
Rimpela, AH ;
Kaprio, JA ;
Berg, MA .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 1997, 7 (01) :29-33
[30]   Safety of modern oral contraception: the options for women: Lessons to be learned [J].
Benagiano, G ;
Primiero, FM .
HUMAN REPRODUCTION UPDATE, 1999, 5 (06) :633-638